Fig. 1
Average global cerebrovascular reactivity index (CVR) in SAH patients and controls. (a) Step 1, normocapnia; (b) Step 2, hypercapnia; and (c) Step 3, return to normocapnia
Study Protocol
After the aneurysm was secured with the patient in stable clinical condition, continuous bilateral TCDs were performed using a PMD 100 Transcranial Doppler System and a 2-MHz transducer fixed in a standard head frame (Spencer Technologies, Seattle, USA). The middle cerebral artery (MCA) was insonated bilaterally through temporal bone windows. Tests were performed in a standard hospital bed with the head elevated at 30°. Once the temporal windows were located, the proper transducer position and angulation were noted and the bilateral probes were fixed on the head frame to prevent motion. The MCA was identified using established TCD criteria: depth from 30 to 60 mm, flow direction toward the transducer, flow velocities from 46 to 86 cm/s, and the anatomic relationship with the internal carotid artery (ICA) bifurcation.
End-tidal CO2 (P ET CO2) values were precisely targeted for cerebrovascular reactivity (CVR) measurements using the method of prospective end-tidal targeting previously described by Slessarev et al. [7]. Blood pressure cuffs or arterial lines, when available, were used to record the blood pressure. After a short acclimatization period, subjects’ P ET CO2 levels were set to 40 mmHg for 2 min (normocapnia; Step 1), 45 mmHg for 2 min (hypercapnia; Step 2), and then back to 40 mmHg (normocapnia; Step 3). The fraction of inspired oxygen (FiO2) was kept at 100 %.
Data Analysis
MCAv was recorded bilaterally for each phase of the test. A global MCAv was generated averaging the means of both hemispheres. MCAv, pulsatility index (PI), end-tidal CO2 and O2 levels, heart rate (HR), blood pressure (BP), and intracranial pressure (ICP), when available, were recorded. The absolute change and percentage change for PETCO2 and MCAv between each step in the protocol were calculated. The CVR index was calculated by dividing the percentage change in MCAv by the absolute change in P ET CO2 (CVR = % ∆ MCAv/1 mmHg ∆ CO2). Separate calculations were made for the right and left side for each step of the test, and both sides were averaged to generate a global CVR (gCVR) index. The mean plus and minus one standard deviation of the control group data were used to define a “normal CVR,” against which the SAH data was compared. The groups were also compared using the definition of “normal CVR” by Marshall et al. [8] as an increase in MCAv of at least 2 % per mmHg of CO2 change. The Mann-Whitney test was used to analyze the differences between MCAv and CO2 levels between the phases and the CVR index between the two groups. To test the association between mean MCAv and CO2 level, a general linear mixed model (CO2 group – SAH versus Control – and interaction between CO2 group) was used. A random intercept model was used to account for variability between patients at baseline and a random slope to account for the variability between patients in the association between MCAv and P ET CO2.
Results
All CVR studies were performed within 7 days after the initial SAH (counted as day 1). Patient demographics and aneurysm location and treatment are shown in Table 1. Baseline PETCO2 levels (mean ± SD), as measured before any gas manipulation, in the SAH group were 32.82 mmHg (±3.73) compared with 37.91 mmHg (±2.83) in the control group (p = 0.0001). There were significant different changes in global blood flow velocity between the two groups during CO2 manipulation, with a dampened response in flow velocity to hypercapnia in the SAH group (Table 2). Global CVR indexes during hypercapnia and back to normocapnia were significantly different between controls and SAH patients (Fig. 1). SAH patients showed impaired reactivity both with hypercapnia (SAH CVR = 0.076 ± 0.034; control CVR = 0.0353 ± 0.011; p = 0.0001), and with the following decrease in CO2 back to normocapnia (baseline CO2 of 40 mmHg; SAH CVR = −0.02 ± 0.018; control CVR = −0.0323 ± 0.013; p = <0.01).
Table 1
Patient demographics and aneurysm characteristics
No. of patients | ||
---|---|---|
Mean age | 52.7 years | |
Women | 7 (39 %) | |
WFNS Grade | ||
I | 8 | |
II | 4 | |
III | 4 | |
IV | 1a | |
V | 1a | |
Aneurysm location | ||
Acom | 5 | |
ICA | 3 | |
MCA | 2 | |
Basilar | 1 | |
PICA | 2 | |
No aneurysm | 5 | |
Aneurysm treatment | ||
Clipped
![]() Stay updated, free articles. Join our Telegram channel![]() Full access? Get Clinical Tree![]() ![]() ![]() |